The Therapeutic Effect of a Biodegradable Long-Acting Intravitreal Implant Containing CGK012 on Neovascular Age-Related Macular Degeneration by Promoting β-Catenin Degradation

Seoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang, Sangtaek Oh, Mary J Meegan · 2025

Read The Therapeutic Effect of a Biodegradable Long-Acting Intravitreal Implant Containing CGK012 on Neovascular Age-Related Macular Degeneration by Promoting β-Catenin Degradation by Seoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang, Sangtaek Oh, Mary J Meegan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12736000.txt.

Description

Seoyoung Park and co-authors report a 2025 study of a slow-release eye implant for a form of age-related sight loss. In this illness, new blood vessels grow under the retina and harm sight. Standard care needs shots in the eye again and again, and some patients respond poorly.

The implant holds a drug called CGK012, which breaks down a protein that drives vessel growth. In cell tests, the drug cut growth and swelling factors and slowed harmful cell change. In rabbits with the vessel growth trait, the loaded implant was tested for effect, release pace, and spread inside the eye.

Catalog record

CREATORSeoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang, Sangtaek Oh, Mary J Meegan
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12736000

Browse the full library · About the Tower of Babel